{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:17:21Z","timestamp":1790036241063,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.metabol.2008.07.015","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T07:42:55Z","timestamp":1221637375000},"page":"S50-S55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S2","title":["Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction"],"prefix":"10.1016","volume":"57","author":[{"given":"Theodore B.","family":"VanItallie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2008.07.015_bib1","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2008.07.015_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1750-3639.1992.tb00683.x","article-title":"Mitochondria and ageing","volume":"2","author":"Muller-Hocker","year":"1992","journal-title":"Brain Pathol"},{"key":"10.1016\/j.metabol.2008.07.015_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1351-5101.2003.00728.x","article-title":"Mitochondiopathies","volume":"11","author":"Finsterer","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070389","article-title":"Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor\u20131","volume":"405","author":"Semenza","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2008.07.015_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.jnen.0000248541.05552.c4","article-title":"Mitochondriopathy in Parkinson's disease and amyotrophic lateral sclerosis","volume":"65","author":"Martin","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. Part 1","volume":"339","author":"Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2008.07.015_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.metabol.2008.07.015_bib8","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2008.07.015_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2008.07.015_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.jcbfm.9600192","article-title":"Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorous magnetic resonance spectroscopy study","volume":"26","author":"Rango","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.metabol.2008.07.015_bib11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","article-title":"Progressive worsening of spatial and chromatic processing deficits in Parkinson disease","volume":"59","author":"Diederich","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson's disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2008.07.015_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000107702","article-title":"A prospective study of familial versus sporadic Parkinson's disease","volume":"4","author":"Papapetropoulos","year":"2007","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.metabol.2008.07.015_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0404.2002.1o040.x","article-title":"Familial and environmental risk factors in Parkinson's disease: a case-control study in northeast Italy","volume":"105","author":"Zorzon","year":"2002","journal-title":"Ann Neurol Scand"},{"key":"10.1016\/j.metabol.2008.07.015_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2008.07.015_bib16","first-page":"191","article-title":"Progress in familial Parkinson's disease","author":"Mizuno","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.metabol.2008.07.015_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000110376","article-title":"Prevalence of movement disorders in elderly community residents","volume":"13","author":"Moghal","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.metabol.2008.07.015_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000110318","article-title":"Worldwide occurrence of Parkinson's disease: an updated review","volume":"12","author":"Zhang","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.metabol.2008.07.015_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","article-title":"A systematic review of depression and mental illness preceding Parkinson's disease","volume":"113","author":"Ishihara","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.metabol.2008.07.015_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.58.6.688","article-title":"Magnetic resonance spectroscopy study of parkinsonism related to boxing","volume":"58","author":"Davie","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.metabol.2008.07.015_bib21","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1212\/01.WNL.0000068008.78394.2C","article-title":"Head trauma preceding PD: a case-control study","volume":"60","author":"Bower","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.20882","article-title":"Head injury and Parkinson's disease risk in twins","volume":"60","author":"Goldman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib23","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000304049.31377.f2","article-title":"(alpha)-Synuclein, pesticides, and Parkinson disease. A case-control study","author":"Brighina","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneur.62.1.91","article-title":"Pesticides and risk of Parkinson disease: a population-based case-control study","volume":"62","author":"Firestone","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bov\u00e9","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.metabol.2008.07.015_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M708597200","article-title":"Complex I is the major site of mitochondrial superoxide production by paraquat","volume":"283","author":"Cochem\u00e9","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2008.07.015_bib27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","article-title":"Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease","volume":"100","author":"Sherer","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2008.07.015_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000080707","article-title":"A fetal risk factor for Parkinson's disease","volume":"26","author":"Barlow","year":"2004","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.metabol.2008.07.015_bib29","first-page":"123","article-title":"Potential sources of increased iron in the substantia nigra of parkinsonian patients","volume":"70","author":"Gerlach","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.metabol.2008.07.015_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2165\/00002512-199914020-00004","article-title":"The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease","volume":"14","author":"Jellinger","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.metabol.2008.07.015_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/dc06-2011","article-title":"Type 2 diabetes and risk of Parkinson's disease","volume":"30","author":"Hu","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2008.07.015_bib32","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000247052.18422.e5","article-title":"Body mass index and the risk of Parkinson disease","volume":"67","author":"Hu","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2008.07.015_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/01.wnl.0000227906.99570.cc","article-title":"Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study","volume":"67","author":"Bower","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1212\/WNL.49.5.1267","article-title":"Smoking and Parkinson's disease: an age-dependent risk effect?","volume":"49","author":"Tzourio","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.metabol.2008.07.015_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson's disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2008.07.015_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.WNL.0000151960.28687.93","article-title":"Physical activity and risk of Parkinson disease","volume":"64","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","article-title":"Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study","volume":"63","author":"de Lau","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.07.015_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.metabol.2008.07.015_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat Genet"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:29:28Z","timestamp":1758425368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049508002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"alternative-id":["S0026049508002552"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2008.07.015","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2008.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}